Group-activity cognitive remediation therapy on cognitive impairment in patients with chronic schizophrenia: a randomized controlled follow-up study

Bahadir H, Yetįmoğlu N, Oflezer Ö, Erkiran M (2024) Mandibular morphology in schizophrenia patients compared with non-psychiatric controls using digital panoramic radiography: a retrospective cross-sectional study from Istanbul, Türkiye. BMC Oral Health 24(1):1170

Article  PubMed  PubMed Central  Google Scholar 

Huang Y, Wang Y, Wang H, Liu Z, Yu X, Yan J et al (2019) Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry 6(3):211–224

Article  PubMed  Google Scholar 

Elvevåg B, Goldberg TE (2000) Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol 14(1):1–21

Article  PubMed  Google Scholar 

Wang Q, Zhou Y, Xu W, Tang W, Liu J (2024) The relationship between attention and suicidal ideation among patients with adult-onset chronic schizophrenia. Brain Behav 14(10):e70079

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bowie CR, Harvey PD (2006) Cognitive deficits and functional outcome in schizophrenia. Neuropsychiatr Dis Treat 2(4):531–536

Article  PubMed  PubMed Central  Google Scholar 

Kane JM, D’Souza DC, Patkar AA, Youakim JM, Tiller JM, Yang R et al (2010) Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study. J Clin Psychiatry 71(11):1475–1481

Article  PubMed  Google Scholar 

Keefe RS, Buchanan RW, Marder SR, Schooler NR, Dugar A, Zivkov M et al (2013) Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far? Schizophr Bull 39(2):417–435

Article  PubMed  Google Scholar 

Lähteenvuo M, Tiihonen J (2021) Antipsychotic polypharmacy for the management of schizophrenia: evidence and recommendations. Drugs 81(11):1273–1284

Article  PubMed  PubMed Central  Google Scholar 

Schennach R, Riedel M, Obermeier M, Spellmann I, Musil R, Jäger M et al (2015) What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial. Eur Arch Psychiatry Clin Neurosci 265(2):107–116

Article  PubMed  Google Scholar 

Hu JJ, Sun XR, Ni SM, Kong Y (2024) Computerized cognitive remediation therapy on cognitive impairment and social function in patients with chronic schizophrenia. World J Psychiatr 14(6):884–893

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization. URL: https://iris.who.int/handle/10665/37958

Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261–276

Article  PubMed  CAS  Google Scholar 

Obermeier M (2012) The positive and negative syndrome scale for schizophrenia, LMU Munich

Randolph C, Tierney MC, Mohr E, Chase TN (1998) The repeatable battery for the assessment of neuropsychological status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 20(3):310–319

Article  PubMed  CAS  Google Scholar 

Duff K, Schoenberg MR, Patton D, Paulsen JS, Bayless JD, Mold J et al (2005) Regression-based formulas for predicting change in RBANS subtests with older adults. Arch Clin Neuropsychol 20(3):281–290

Article  PubMed  Google Scholar 

Villalta-Gil V, Roca M, Gonzalez N, Domènec E, Cuca, Escanilla A et al (2009) Dog-assisted therapy in the treatment of chronic schizophrenia inpatients. Anthrozoös 22(2):149–159

Article  Google Scholar 

Velligan DI, Kern RS, Gold JM (2006) Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies. Schizophr Bull 32(3):474–485

Article  PubMed  PubMed Central  Google Scholar 

Bowie CR, Grossman M, Gupta M, Oyewumi LK, Harvey PD (2014) Cognitive remediation in schizophrenia: efficacy and effectiveness in patients with early versus long-term course of illness. Early Interv Psychiatry 8(1):32–38

Article  PubMed  Google Scholar 

Roberts MT, Lloyd J, Välimäki M, Ho GW, Freemantle M, Békefi AZ (2021) Video games for people with schizophrenia. Cochrane Database Systematic Rev 2(2):Cd012844

Google Scholar 

Venet-Kelma L, Morvan Y, Romain AJ, Mendy M, Meslier M, Thoisy I et al (2024) Effect of an adapted physical activity program on stress, anxiety, depression in patients with schizophrenia: study protocol of a randomized-controlled trial. Eur Arch Psychiatry Clin Neurosci 274(4):891–902

Article  PubMed  Google Scholar 

Vita A, Gaebel W, Mucci A, Sachs G, Barlati S, Giordano GM et al (2022) European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia. Eur Psychiatry 65(1):e57

Article  PubMed  PubMed Central  Google Scholar 

Molina JL, Joshi YB, Nungaray JA, Sprock J, Attarha M, Biagianti B et al (2024) Early auditory processing abnormalities alter individual learning trajectories and sensitivity to computerized cognitive training in schizophrenia. Psychol Med 54(10):2669–2676

Article  PubMed  Google Scholar 

Burlingame GM, Svien H, Hoppe L, Hunt I, Rosendahl J (2020) Group therapy for schizophrenia: a meta-analysis. Psychotherapy 57(2):219–236

Article  PubMed  Google Scholar 

Favrod J, Nguyen A, Tronche AM, Blanc O, Dubreucq J, Chereau-Boudet I et al (2019) Impact of positive emotion regulation training on negative symptoms and social functioning in schizophrenia: a field test. Front Psychiatry 10:532

Article  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif